Synthetic Essentiality of TRAIL in VHL-Deficient Renal Cell Carcinoma
Personalized briefing
Discovery of the day · Cell Biology
Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma
Dear Abdel Halim Harrath, this is your personalized scientific intelligence briefing — curated for your work in Cell Biology.
Key finding
Oncology · Cell Biology
Discovery of the day
This study identifies a synthetic essential relationship between the transcription factor HIF2α and the death ligand TRAIL (TNFSF10) in clear cell renal cell carcinoma (ccRCC) driven by von Hippel–Lindau (VHL) loss. The researchers demonstrate that TRAIL is a direct transcriptional target of HIF2α, and that its expression becomes essential for the survival of VHL-deficient ccRCC cells under conditions of HIF2α activation. For your interests in cellular mechanisms of disease and aging, this finding reveals a previously unrecognized dependency that links hypoxia signaling to the apoptosis machinery, offering a potential therapeutic vulnerability in a common cancer type that may also inform how programmed cell death is co-opted in developmental and aging-related contexts.
Novelty
92%
Rigor
85%
Significance
90%
Validity
83%
Clarity
91%
Advertisement
ScientificChina — The Global Marketplace for Scientific and Medical Equipments Start Browsing →
Your briefing is personalized based on your selected fields, keywords, and research interests.
